SCD and nonpapillary renal cell carcinoma: Importantly, because SCD1 was over-expressed in ccRCC, SCD1 inhibition via pharmacological and genetic manipulation could lead to the reduction in cell viability due to a diminished proliferation rate (Melana et al., 2021).